Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice

Shigehiro Ohdo, Tomoko Makinosumi, Takashi Ishizaki, Eiji Yukawa, Shun Higuchi, Shigeyuki Nakano, Nobuya Ogawa

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The mechanisms underlying the circadian rhythm of the toxicity induced by irinotecan hydrochloride (CPT-11; 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin) were investigated from the viewpoint of the sensitivity of living organisms and the pharmacokinetics of the drug. ICR male mice were housed under standardized light-dark cycle conditions (lights on at 0700, off at 1900) with food and water ad libitum. The loss of body weight after an intraperitoneal injection of CPT-11 (100 mg/kg) was more serious in the late dark and the early light and milder in the late light and the early dark. The CPT-11-induced leukopenia was more serious in the late dark and milder in the late light. The lower toxicity of CPT-11 was observed when DNA synthesis and type 1 DNA topoisomerase activity in bone marrow cells decreased and the higher toxicity was observed when these activities began to increase. There were circadian stage-dependent changes in the concentrations of CPT-11 and its major metabolite (SN-38; 7-ethyl-10-hydroxycamptothecin) in plasma. The higher concentrations of CPT-11 and SN-38 in plasma were observed when the level of CPT-11-induced toxicity increased. The present study suggests that the toxicity of CPT-11 is influenced by circadian rhythm- dependent processes.

Original languageEnglish
Pages (from-to)1383-1388
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume283
Issue number3
Publication statusPublished - Dec 1 1997

Fingerprint

irinotecan
Cell Cycle
Light
Circadian Rhythm

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Ohdo, S., Makinosumi, T., Ishizaki, T., Yukawa, E., Higuchi, S., Nakano, S., & Ogawa, N. (1997). Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. Journal of Pharmacology and Experimental Therapeutics, 283(3), 1383-1388.

Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. / Ohdo, Shigehiro; Makinosumi, Tomoko; Ishizaki, Takashi; Yukawa, Eiji; Higuchi, Shun; Nakano, Shigeyuki; Ogawa, Nobuya.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 283, No. 3, 01.12.1997, p. 1383-1388.

Research output: Contribution to journalArticle

Ohdo, S, Makinosumi, T, Ishizaki, T, Yukawa, E, Higuchi, S, Nakano, S & Ogawa, N 1997, 'Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice', Journal of Pharmacology and Experimental Therapeutics, vol. 283, no. 3, pp. 1383-1388.
Ohdo S, Makinosumi T, Ishizaki T, Yukawa E, Higuchi S, Nakano S et al. Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. Journal of Pharmacology and Experimental Therapeutics. 1997 Dec 1;283(3):1383-1388.
Ohdo, Shigehiro ; Makinosumi, Tomoko ; Ishizaki, Takashi ; Yukawa, Eiji ; Higuchi, Shun ; Nakano, Shigeyuki ; Ogawa, Nobuya. / Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. In: Journal of Pharmacology and Experimental Therapeutics. 1997 ; Vol. 283, No. 3. pp. 1383-1388.
@article{b3b902491a83468f8939dc044d4a2007,
title = "Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice",
abstract = "The mechanisms underlying the circadian rhythm of the toxicity induced by irinotecan hydrochloride (CPT-11; 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin) were investigated from the viewpoint of the sensitivity of living organisms and the pharmacokinetics of the drug. ICR male mice were housed under standardized light-dark cycle conditions (lights on at 0700, off at 1900) with food and water ad libitum. The loss of body weight after an intraperitoneal injection of CPT-11 (100 mg/kg) was more serious in the late dark and the early light and milder in the late light and the early dark. The CPT-11-induced leukopenia was more serious in the late dark and milder in the late light. The lower toxicity of CPT-11 was observed when DNA synthesis and type 1 DNA topoisomerase activity in bone marrow cells decreased and the higher toxicity was observed when these activities began to increase. There were circadian stage-dependent changes in the concentrations of CPT-11 and its major metabolite (SN-38; 7-ethyl-10-hydroxycamptothecin) in plasma. The higher concentrations of CPT-11 and SN-38 in plasma were observed when the level of CPT-11-induced toxicity increased. The present study suggests that the toxicity of CPT-11 is influenced by circadian rhythm- dependent processes.",
author = "Shigehiro Ohdo and Tomoko Makinosumi and Takashi Ishizaki and Eiji Yukawa and Shun Higuchi and Shigeyuki Nakano and Nobuya Ogawa",
year = "1997",
month = "12",
day = "1",
language = "English",
volume = "283",
pages = "1383--1388",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice

AU - Ohdo, Shigehiro

AU - Makinosumi, Tomoko

AU - Ishizaki, Takashi

AU - Yukawa, Eiji

AU - Higuchi, Shun

AU - Nakano, Shigeyuki

AU - Ogawa, Nobuya

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The mechanisms underlying the circadian rhythm of the toxicity induced by irinotecan hydrochloride (CPT-11; 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin) were investigated from the viewpoint of the sensitivity of living organisms and the pharmacokinetics of the drug. ICR male mice were housed under standardized light-dark cycle conditions (lights on at 0700, off at 1900) with food and water ad libitum. The loss of body weight after an intraperitoneal injection of CPT-11 (100 mg/kg) was more serious in the late dark and the early light and milder in the late light and the early dark. The CPT-11-induced leukopenia was more serious in the late dark and milder in the late light. The lower toxicity of CPT-11 was observed when DNA synthesis and type 1 DNA topoisomerase activity in bone marrow cells decreased and the higher toxicity was observed when these activities began to increase. There were circadian stage-dependent changes in the concentrations of CPT-11 and its major metabolite (SN-38; 7-ethyl-10-hydroxycamptothecin) in plasma. The higher concentrations of CPT-11 and SN-38 in plasma were observed when the level of CPT-11-induced toxicity increased. The present study suggests that the toxicity of CPT-11 is influenced by circadian rhythm- dependent processes.

AB - The mechanisms underlying the circadian rhythm of the toxicity induced by irinotecan hydrochloride (CPT-11; 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin) were investigated from the viewpoint of the sensitivity of living organisms and the pharmacokinetics of the drug. ICR male mice were housed under standardized light-dark cycle conditions (lights on at 0700, off at 1900) with food and water ad libitum. The loss of body weight after an intraperitoneal injection of CPT-11 (100 mg/kg) was more serious in the late dark and the early light and milder in the late light and the early dark. The CPT-11-induced leukopenia was more serious in the late dark and milder in the late light. The lower toxicity of CPT-11 was observed when DNA synthesis and type 1 DNA topoisomerase activity in bone marrow cells decreased and the higher toxicity was observed when these activities began to increase. There were circadian stage-dependent changes in the concentrations of CPT-11 and its major metabolite (SN-38; 7-ethyl-10-hydroxycamptothecin) in plasma. The higher concentrations of CPT-11 and SN-38 in plasma were observed when the level of CPT-11-induced toxicity increased. The present study suggests that the toxicity of CPT-11 is influenced by circadian rhythm- dependent processes.

UR - http://www.scopus.com/inward/record.url?scp=0031471160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031471160&partnerID=8YFLogxK

M3 - Article

C2 - 9400014

AN - SCOPUS:0031471160

VL - 283

SP - 1383

EP - 1388

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -